Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/3/2025

Light Therapy for Advanced Sleep-Wake Phase Disorder

Introduction to Light Therapy

  • The American Academy of Sleep Medicine recommends light therapy for patients with advanced sleep-wake phase disorder (ASWPD) to achieve a 10:30 PM bedtime, using 2,500-10,000 lux broad-spectrum white light for 1-2 hours duration in the evening between 7:00-9:00 PM 1, 2, 3, 4, 5, 6

Timing: Evening Light Exposure (7:00-9:00 PM)

  • Light must be administered during the phase delay portion of the circadian phase response curve, which occurs in the evening hours for patients with ASWPD 1, 2, 3, 4, 5, 6
  • The 7:00-9:00 PM window is specifically recommended by the American Academy of Sleep Medicine and geriatric sleep guidelines to delay circadian rhythms and push bedtime later 1, 2, 3, 4, 5, 6

Dose: 2,500-10,000 Lux Broad-Spectrum Light

  • Bright light therapy should deliver 2,500-10,000 lux of broad-spectrum white light 1, 2, 3, 4, 5, 6
  • Lower light intensities may not effectively delay sleep phase 1, 2, 3, 4, 5, 6

Duration: 1-2 Hours Per Session

  • Each evening light therapy session should last 1-2 hours 1, 2, 3, 4, 5, 6
  • The patient should remain seated in front of the light box during this period, though they can engage in other activities like reading 1, 2, 3, 4, 5, 6

Treatment Course: Continue Until Target Achieved

  • Continue daily evening light therapy until the desired 10:30 PM bedtime is consistently achieved 1, 2, 3, 4, 5, 6
  • The exact length of treatment has not been definitively established, but therapy should be maintained until circadian phase has adequately delayed 1, 2, 3, 4, 5, 6

Adjunctive Behavioral Interventions

  • Combine light therapy with good sleep hygiene practices and behavioral adjustments to delay sleep-wake times 1, 2, 4, 5, 6
  • Avoid bright light exposure in the early morning hours, which would counteract the evening light therapy by advancing circadian phase 1, 2, 4, 5, 6

Important Safety Considerations

  • Screen patients with ophthalmologic disease (cataracts, retinal conditions) before initiating light therapy and consider specialist evaluation 1, 2, 3, 4, 5, 6
  • Exercise caution in patients with preexisting mania, retinal photosensitivity, or migraine 1, 2, 3, 4, 5, 6
  • Common side effects include mild headache, nausea, vomiting, and self-limited visual problems 1, 2, 3, 4, 5, 6
  • Ultraviolet rays are filtered by light boxes, making them generally safe 1, 2, 3, 4, 5, 6

Evidence Strength and Clinical Nuances

  • The American Academy of Sleep Medicine has confirmed the usefulness of light therapy for circadian rhythm sleep disorders including ASWPD 1, 2, 3, 4, 5, 6
  • Multiple studies demonstrate successful phase delay with evening light therapy, with additional benefits including improved sleep efficiency and total sleep time 1, 2, 4, 5, 6
  • Older adults may have reduced response to light therapy compared to younger individuals, and blue light may be less effective in older populations 1, 2, 3, 4, 5, 6
  • Despite this, broad-spectrum white light in the 2,500-10,000 lux range remains the evidence-based recommendation 1, 2, 3, 4, 5, 6
  • Melatonin is not recommended for ASWPD, as morning melatonin administration (which would theoretically delay phase) lacks efficacy data and may cause residual morning sleepiness 1, 2, 3, 4